Clinical Trial Update: Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks

View source ↗

Summary

This trial update reports on the effectiveness and safety outcomes of an eight-week regimen combining Paritaprevir, Ombitasvir, Ritonavir, and Dasabuvir for Hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Paritaprevir/Ombitasvir/Ritonavir/Dasabuvir

Snippet

Sponsor: Hepa C | Conditions: Hepatitis C Infection | Status: COMPLETED